Gene therapy targets Canavan disease

被引:0
|
作者
Steinberg, D
机构
来源
SCIENTIST | 2001年 / 15卷 / 18期
关键词
D O I
暂无
中图分类号
G25 [图书馆学、图书馆事业]; G35 [情报学、情报工作];
学科分类号
1205 ; 120501 ;
摘要
引用
收藏
页码:20 / +
相关论文
共 50 条
  • [1] Gene therapy for Canavan disease?
    Fink, DJ
    [J]. ANNALS OF NEUROLOGY, 2000, 48 (01) : 9 - 10
  • [2] Targeted aspartoacylase gene therapy reverts Canavan disease
    Starling, Shimona
    [J]. NATURE REVIEWS NEUROLOGY, 2018, 14 (01) : 4 - 4
  • [3] Targeted aspartoacylase gene therapy reverts Canavan disease
    Shimona Starling
    [J]. Nature Reviews Neurology, 2018, 14 : 4 - 4
  • [4] Gene Therapy for Canavan's Disease Takes a Step Forward
    Ahmed, Seemin S.
    Gao, Guangping
    [J]. MOLECULAR THERAPY, 2013, 21 (03) : 505 - 506
  • [5] Canavan gene therapy protocol
    Levine, RJ
    [J]. SCIENCE, 1996, 272 (5265) : 1085 - 1085
  • [6] EFFICACIOUS AND SAFE GENE THERAPY FOR CANAVAN DISEASE: A NOVEL APPROACH
    Gao, G.
    Su, Q.
    Michals-Matalon, K.
    Matalon, R.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S234 - S234
  • [7] Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair
    Lotun, Anoushka
    Gessler, Dominic J.
    Gao, Guangping
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [8] AAV-BASED GENE THERAPY APPROACHES FOR THE TREATMENT OF CANAVAN DISEASE
    Jonquieres, G.
    Mersmann, N.
    Teahan, O.
    Klugmann, C. B.
    Harasta, A. E.
    Lutz, B.
    Housley, G. D.
    Klugmann, M.
    [J]. CYTOTHERAPY, 2013, 15 (04) : S12 - S12
  • [9] Targeting oligodendrocytes in rAAV mediated gene replacement therapy for Canavan disease
    Jonquieres, G. V.
    Mersmann, N.
    Klugmann, C.
    Harrasta, A.
    Klugmann, M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 289 - 289
  • [10] Substrate reduction therapy for Canavan disease
    Wang, Qinzhe
    Zhao, Mojun
    Parungao, Gwenn
    Thangavelu, Bharani
    Mutthamsetty, Vinay
    Viola, Ronald
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252